400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
2018-01-01
信使RNA治疗剂开发商
医药研发/制造
化学&生物药
2017-01-23
一家创新的英国诊断公司
医疗器械
体外诊断试剂
Consort Medical;
Consort Medical;
Johnson & Johnson Innovation;
Johnson & Johnson Innovation;
Global Life Science Ventures;
Medical Technology Venture Partners;
RMI Partners;
诺华;
BB Biotech Ventures
2017-01-23
分子诊断平台提供商
医疗信息化
电子健康档案(EHR)
BB Biotech Ventures;
BB Biotech Ventures;
Consort Medical;
Consort Medical;
Global Life Science Ventures;
Johnson & Johnson Innovation;
诺华;
RMI Partners;
Technology Venture Partners;
万孚生物
2015-01-29
分子诊断平台提供商
医疗信息化
电子健康档案(EHR)
Consort Medical;
Consort Medical;
Johnson & Johnson Development Corporation;
Johnson & Johnson Development Corporation;
Life Science Partners;
RMI Partners;
诺华;
BB Biotech Ventures;
South West Ventures Fund
2015-01-29
一家创新的英国诊断公司
医疗器械
体外诊断试剂
Consort Medical;
Consort Medical;
Johnson & Johnson Innovation;
Johnson & Johnson Innovation;
Global Life Science Ventures;
Medical Technology Venture Partners;
RMI Partners;
诺华;
BB Biotech Ventures
2014-09-11
一家生物制药公司
医药研发/制造
化学&生物药
Idinvest Partners;
Idinvest Partners;
Ysios Capital Partners;
Ysios Capital Partners;
Gilde Healthcare;
Inventages Venture Capital;
BB Biotech Ventures;
AbbVie Biotech Ventures
2014-04-28
一家创新的英国诊断公司
医疗器械
体外诊断试剂
Consort Medical;
Consort Medical;
Johnson & Johnson Development Corporation;
Johnson & Johnson Development Corporation;
RMI Partners;
诺华;
Life Sciences Partners;
BB Biotech Ventures
2013-04-25
药物研发公司
医药研发/制造
化学&生物药
MPM Capital;
MPM Capital;
MPM Bio IV NVS Strategic Fund;
MPM Bio IV NVS Strategic Fund;
Biotech Growth;
BB Biotech Ventures;
Brookside Capital
2012-01-04
一家私营生物制药公司
医药研发/制造
化学&生物药
HBM Healthcare;
HBM Healthcare;
Andera Partners;
Andera Partners;
Biogen;
TVM Capital;
Life Sciences Partners;
BB Biotech Ventures
2011-12-16
药物研发公司
医药研发/制造
化学&生物药
Saints Capital;
Saints Capital;
Scottish Widows;
Scottish Widows;
MPM Capital;
Wellcome Trust;
HealthCare Ventures;
BB Biotech Ventures;
Brookside Capital
GlobeNewswire2026-03-10
PRNewswire2026-03-10
PRNewswire2026-03-10
GlobeNewswire2026-03-10
PRNewswire2026-03-10
GlobeNewswire2026-03-10
PRNewswire2026-03-10
GlobeNewswire2026-03-10
PRNewswire2026-03-10
PRNewswire2026-03-10